CDKN2A and ductal breast carcinoma in situ: Gauthier and colleagues have recently shown that in ductal carcinoma in situ (DCIS) lesions, high p16INK4a together with low Ki-67 (proliferation) appears to not promote tumour progression, while high p16INK4a and high Ki-67 lead to subsequent tumours [24].